To evaluate if treatment with a new medication reduces the risk of cardiovascular disease in overweight or obese patients.
Cardiovascular disease & care
Your participation in this study would be for approximately four years.There will be approximately 25 visits over this time period. During these visits you will be asked about your health and medications and have a physical examination, blood test and ECG.You will be reimbursed for travel and study expenses.Sign up to this clinical trial below.
|Eligibility Criteria|| |
To be considered for the study you must meet the following criteria:
For further information click here.
Dr David B Cross
MBBS, FRACP, FCSANZ
General cardiologistWorks at 4 centres.
Dr Peter Purnell
M.B.B.S. (UWA) F.R.A.C.P. F.C.S.A.N.Z
Cardiovascular Imaging SpecialistJoondalup – Shenton House (Cardiology)